Search News + Media

A new, three-year NIH grant will expand Dr. Elizabeth Yen's research and initial pilot study findings about the effects of prenatal opioid exposure in an infant's first year of life.

Targeted genome sequencing found to deliver routine results more quickly and at a lower cost; lack of standardization in analytic techniques remains a barrier to diagnosis and medical care for genetic disorders in the first year of life.

Lowell General Hospital recently went live with a new state-of-the art camera system in the Special Care Nursery (NICU unit).

MIRI researchers are now able to identify genes affecting abnormal feeding habits in newborns who were prenatally exposed to opioids.

Tufts Medical Center and Prapela have been awarded a joint $2.5 million grant from the National Institute on Drug Abuse to help advance the development hospital bassinets for the treatment of newborns diagnosed with Neonatal Abstinence Syndrome (NAS)/Neonatal Opioid Withdrawal Syndrome (NOWS).

A national clinical trial led by Tufts Children’s Hospital researchers has found that both targeted genome sequencing and whole genome sequencing may help diagnose genetic abnormalities in neonates and infants. However, the technology and interpretations of results continue to have significant limitations that require further research and understanding.

Alexander Biddell was born with a rare condition that caused the central region of his neck to not develop properly. Luckily, Dr. Alexander Marston an otolaryngologist at Tufts Medical Center at Tufts Medical Center was able to diagnose and treat him.

Working with licensed therapists, our physicans are using music exposure to help improve the health of babies in the neonatal intensive care unit (NICU).